Tempest Therapeutics Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/B Ratio1.903.160.671.01
Price/Tangible Book1.903.160.671.01
Enterprise Value Ratios
Profitability & Returns
Return on Equity (ROE)-1.82%-1.31%-1.32%-1.05%-1.97%
Return on Assets (ROA)-0.56%-0.37%-0.36%-0.35%-0.79%
Return on Capital Employed (ROCE)-1.54%-0.69%-0.89%-0.51%-0.98%
Leverage & Solvency Ratios
Debt/Equity0.800.771.220.510.14
Liquidity Ratios
Current Ratio2.214.294.533.446.15
Quick Ratio2.134.174.292.595.84
Efficiency Ratios
Yield & Distribution Ratios
Earnings Yield-1.15%-0.35%-2.95%-0.78%
FCF Yield-0.92%-0.33%-2.62%-0.72%
Buyback Yield-0.81%-0.33%-2.05%-7.10%0.44%